In a model of non-alcoholic steatohepatitis, long-term use of beinaglutide reduced liver weight and hepatic steatosis and improved insulin sensitivity, and increased Sirt1 gene expression levels improved hepatic insulin resistance [78]. Here, INS is linked to Insulin resistance.